Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
21 hedge funds and large institutions have $10.2M invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 22 → 21 (-1)
32% less capital invested
Capital invested by funds: $14.9M → $10.2M (-$4.75M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$41.8K |
| 2 |
SCM
Saba Capital Management
New York
|
+$2.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 2 |
UM
Ulysses Management
New York
|
-$1.33K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$157 |
CTV.WS Hedge Fund Activity: Q4 2022 in Review
21 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q4 2022, worth a combined $10.2M — down 32% from $14.9M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CTV.WS and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Altshuler Shaham, opening a new position worth an estimated $41.8K. The largest seller was UBS Group, exiting entirely with an estimated $2K sold.
- 21 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q4 2022, down from 22 in Q3 2022.
- Funds reported $10.2M of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q4 2022, down 32% quarter-over-quarter.
- 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q4 2022 was Altshuler Shaham, an estimated $41.8K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q4 2022 was UBS Group, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2022.